CPRX Stock Rises 17% on Settling Firdapse Patent Litigation With Teva

Published on 9 Jan 2025 on Zacks · via Yahoo Finance

In the same year, the company also acquired North American commercial and developmental rights to...

Read the rest of the article

Start tracking your investments with Statfolio

In the same year, the company also acquired North American commercial and developmental rights to...

Zacks · via Yahoo Finance 9 Jan 2025

On Wednesday, Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) entered into a settlement agreement wit...

Benzinga · via Yahoo Finance 9 Jan 2025

Catalyst Pharmaceutical (CPRX) Coral Gables, FL-based Catalyst Pharmaceuticals, Inc. is a...

Zacks · via Yahoo Finance 7 Jan 2025

We recently compiled a list of the 10 Best Performing Biotech Stocks in 2024. In this article, we...

Insider Monkey · via Yahoo Finance 24 Dec 2024

Catalyst Pharmaceuticals (NASDAQ:CPRX) has had a great run on the share market with its stock up ...

Simply Wall St. · via Yahoo Finance 4 Dec 2024

Catalyst Pharmaceuticals Inc (CPRX) reports a 25.3% increase in total revenue and updates its...

GuruFocus.com · via Yahoo Finance 11 Nov 2024

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) is set to release its Q3 2024 earnings on Nov 7, 2024....

GuruFocus.com · via Yahoo Finance 6 Nov 2024

On August 20, 2024, Steve Miller, the Chief Operating & Scientific Officer of Catalyst Pharmaceut...

GuruFocus.com · via Yahoo Finance 20 Aug 2024

Most readers would already know that Catalyst Pharmaceuticals' (NASDAQ:CPRX) stock increased by 4...

Simply Wall St. · via Yahoo Finance 19 Jun 2024

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q1 2024 Earnings Call Transcript May 9, 2024 Catalys...

Insider Monkey via Yahoo Finance 10 May 2024